Hey mate. I don't do not believe that is correct.
In the announcement it mentions 1% is to do with audio quality and not the patients themselves as you stated:
"Only approximately 1% of recordings have been found in the quality assurance process to be unacceptable. "
My current understanding is that 70% of the audio collected last year was done improperly because the patient was treated before hand, or because there was obstruction in the audio (other sounds besides coughs [background noise], interference from electronic equipment etc.)
Now that the testing is under strict guidelines, only 1% of audio recordings have been found inadequate. Last year this number was around 70% inadequate but was only caught at the very end of the testing because there was limited or no quality control put in place at the time.
Feel free to correct me if my understanding is not right here.
- Forums
- ASX - By Stock
- RAP
- Ann: ResApp Provides SMARTCOUGH-C-2 Study Update
Ann: ResApp Provides SMARTCOUGH-C-2 Study Update, page-41
-
- There are more pages in this discussion • 29 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RAP (ASX) to my watchlist
(20min delay)
|
|||||
Last
20.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $176.2M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
RAP (ASX) Chart |
Day chart unavailable